The effect of elexacaftor–tezacaftor–ivacaftor on liver stiffness in children with cystic fibrosis
ETI treatment could positively affect CFHBI in children with CF, as demonstrated by reduced liver stiffness during treatment.
Authors
- C.R. Hansen (ORCID: https://orcid.org/0000-0001-9705-0335)
- H. Elídóttir (ORCID: https://orcid.org/0000-0002-8608-8909)
- Erik A. Eklund (ORCID: https://orcid.org/0000-0003-1902-4865)
- Lisa I. Påhlman
- Stefanie Diemer
Institutions
- Lund University (SE)
- National University Hospital of Iceland (IS)
- Wallenberg Wood Science Center (SE)
- Skåne University Hospital (SE)
Publication Details
- Journal
- Journal of Pediatric Gastroenterology and Nutrition
- Published
- 2025-04-23
- DOI
- https://doi.org/10.1002/jpn3.70050
- Citations
- 2
- Primary Topic
- Cystic Fibrosis Research Advances
- Type
- article
- Field-Weighted Citation Impact
- 3.04
Funders
- Lunds Universitet
- Skånes universitetssjukhus